Articles On Capitol Health (ASX:CAJ)

With interest rates rising, many experts are urging investors to buy ASX shares that can maintain revenue through tough times. One such sector is health, where the logic is that Australians will still need to treat their illnesses and inju...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Can you believe May 2022 is here already? There are a number of ASX shares brokers rate as buys this month. This article is about two smaller businesses that could be opportunities for investors to consider. Here are two buy-rated stocks:...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Australian small caps are pushing higher in 2022 after a shaky start to the year. The large end of the market in the S&P/ASX 200 Index (ASX: XJO) has climbed 41 basis points today and sits at 7,417, having rallied 6% in the past month....

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AIZ)) - Air New Zealand ((ART)) - Airtasker ((APX)) - Appen ((ALX)) - Atlas Arteria ((AIA)) - Auckland International Airport ((AMI)) - Aurelia Metals ((ACL)) - Australia...

At the time of writing, the ASX 200 Health Index (XHJ) is down by 1.10%, while the benchmark ASX 200 has fallen by 2.15%. It’s all about earnings today for ASX health stocks. Here’s a highlight of where they stand in the first half.   Round...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

The Montgomery Fund recently invested in Integral Diagnostics (ASX:IDX), which provides medical imaging services at 67 radiology clinics across Australia and New Zealand. Our investment in IDX gives us exposure to an expanding business in t...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Weekly update on stockbroker recommendation, target price, and earnings forecast changes. By Mark Woodruff Guide: The FNArena database tabulates the views of seven major Australian and international stock brokers: Citi, Credit Suisse, Macqu...

World Overnight SPI Overnight 7368.00 – 2.00 – 0.03% S&P ASX 200 7369.90 – 50.50 – 0.68% S&P500 4688.67 – 12.23 – 0.26% Nasdaq Comp 15921.57 – 52.28 – 0.33% DJIA 35931.05 – 211.17 – 0.58% S&P500 VIX 17.11 + 0.74 4....

The S&P/ASX 200 (ASX: XJO) fell another 0.7% on Tuesday despite strong comments from the Reserve Bank of Australia Governor who confirmed interest rates would be going nowhere until at least 2024. Every sector finished lower barring tec...

Highlights Imugene shares rose nearly 9% on signing a new clinical trial supply agreement. OZ Minerals’ share price fell even after it hiked its total copper reserve estimates. Resimac Group shares dropped following earnings report fo...

The benchmark S&P/ASX 200 index (ASX: XJO) has slipped 0.75% into the red today at 7,414 points. The S&P/ASX 200 Healthcare Index (ASX: XHJ) is leading the broad market’s losses and has sunk 1.12% at the time of writing. Despite t...

Highlights The ASX 200 had dropped as much as 0.6% by mid-session on Tuesday. Barring A-REIT, all sectoral indices were trading in the red. Mesoblast, Nearmap, Zip Co were among top losers on the ASX. Investors are keeping their eyes...

Highlights Benchmark index, the ASX 200, was trading around 0.3% lower at 7,440 in early trade. Falling commodity prices are putting pressure on resource-heavy stocks. The US dollar surged to a 16-month high on Monday. The Austral...

The ASX 200 Health Index (XHJ) is down by 0.30% at the time of writing, compared to the broader index which is down by 0.50%. Imugene (ASX:IMU) was up 4.35% in morning trading, after announcing partnership agreements  with Merck KGaA and Pf...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

The Healius Ltd (ASX: HLS) share price tumbled by 8% today, after releasing its FY21 results. Can the Healius share price bounce back over the long run? Healius is a healthcare business that provides pathology, diagnostic imaging and operat...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((A2M)) - a2 Milk Co ((AIM)) - Ai-Media Technologies ((AGI)) - Ainsworth Game Technology ((AIZ)) - Air New Zealand ((ANP)) - Antisense Therapeutics ((APX)) - Appen ((ALG))...

WAM Microcap Limited (ASX: WMI) reported its FY21 result this week. Could it be the best ASX dividend share around? WAM Microcap is a listed investment company (LIC) that targets businesses with market capitalisations below $300 million at...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

MELBOURNE, Australia, July 27, 2021 /PRNewswire/ — Capital Radiology, a leading provider of diagnostic imaging services in Australia, has partnered with PageUp to enhance its talent acquisition framework with best-in-class recruitment softw...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

If I were given $2,000 to invest into ASX shares, I know the two stocks I’d want to pick. I believe that businesses that are smaller have more growth potential. In my opinion, the following two options are good ideas: WAM Microcap Limited...

The merger and acquisition (M&A) frenzy has turned up the heat over the past few months, reaching record levels. According to Reuters, global M&A activity in the last quarter surpassed all previous records. While deals in the Unite...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Ask A Fund Manager In part 1 of our interview, 1851 Capital portfolio manager Martin Hickson explained why Uniti’s business model is irresistible. Now in part 2, he tells us how he regrets the way his fund launched last year and the 8 stoc...

Ask A Fund Manager The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In part 1 of our interview, 1851 Capital portfolio manager Martin Hickson tells us the telecommunications company...

The fund manager of listed investment company (LIC) WAM Active Limited (ASX: WAA) has sold the shares of EML Payments Ltd (ASX: EML). What is WAM Active? It’s a relatively small LIC that is run by the investment team at Wilson Asset Manage...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

The diagnostics imaging industry has come a long way since the days of X-rays and CT scans – two technologies that have been around for decades. Although they have not been replaced entirely, a breed of new ASX small caps have emerged over...

The last time the Healius Limited (ASX: HLS) share price was hovering at current levels was in 2018 when the winter Olympic games was in Korea. What has happened to the Healius share price since then and how will the recent trading update i...

ASX microcap stocks have been performing particularly well for Wilson Asset Management. In fact, of Wilson’s seven ASX Listed Investment Companies, its Microcap fund (ASX:WMI) has performed the best, up 83 per cent in the last year and 12 p...

There are a few top-performing small cap ASX shares that delivered strong performance in March 2021 that helped the 1851 Emerging Companies Fund outperform its benchmark. What’s 1851 Emerging Companies Fund? It’s a fund that invests on sma...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Respected fund manager Wilson Asset Management (WAM) has recently identified two ASX shares that it owns in its portfolio. WAM operates several listed investment companies (LICs). Two of those LICs are WAM Capital Limited (ASX: WAM) and WA...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AMA)) - Ama Group ((APA)) - APA Group ((APX)) - Appen ((AVG)) - Aust Vintage ((ASG)) - Autosports Group ((BGA)) - Bega Cheese ((BTH)) - Bigtincan Holdings ((BKL)) - Blac...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...